Cutler Group’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Hold
0
1628
2023
Q4
Hold
0
1839
2023
Q3
Sell
-1,200
Closed -$23K 1877
2023
Q2
$23K Sell
1,200
-2,363
-66% -$45.3K ﹤0.01% 796
2023
Q1
$67K Buy
3,563
+2,707
+316% +$50.9K 0.01% 568
2022
Q4
$19K Buy
856
+636
+289% +$14.1K ﹤0.01% 1111
2022
Q3
$5K Sell
220
-380
-63% -$8.64K ﹤0.01% 1560
2022
Q2
$14K Buy
+600
New +$14K ﹤0.01% 1290
2021
Q4
Sell
-1,200
Closed -$50K 2508
2021
Q3
$50K Sell
1,200
-222
-16% -$9.25K ﹤0.01% 1207
2021
Q2
$55K Buy
1,422
+1,222
+611% +$47.3K ﹤0.01% 1203
2021
Q1
$6K Sell
200
-3,200
-94% -$96K ﹤0.01% 1744
2020
Q4
$154K Buy
+3,400
New +$154K 0.01% 644
2020
Q3
Hold
0
2171
2020
Q2
Sell
-1,800
Closed -$58K 1993
2020
Q1
$58K Buy
1,800
+600
+50% +$19.3K ﹤0.01% 735
2019
Q4
$49K Buy
1,200
+300
+33% +$12.3K ﹤0.01% 906
2019
Q3
$32K Sell
900
-6,400
-88% -$228K ﹤0.01% 941
2019
Q2
$375K Buy
7,300
+4,400
+152% +$226K 0.03% 305
2019
Q1
$166K Sell
2,900
-1,300
-31% -$74.4K 0.02% 502
2018
Q4
$176K Sell
4,200
-1,400
-25% -$58.7K 0.02% 432
2018
Q3
$422K Buy
5,600
+5,233
+1,426% +$394K 0.03% 383
2018
Q2
$26K Sell
367
-533
-59% -$37.8K ﹤0.01% 1066
2018
Q1
$26K Sell
900
-7,357
-89% -$213K ﹤0.01% 1119
2017
Q4
$274K Buy
8,257
+4,504
+120% +$149K 0.01% 528
2017
Q3
$123K Buy
+3,753
New +$123K ﹤0.01% 917
2017
Q2
Hold
0
3208